J.P. Morgan (NYSE: JPM) has a $46 price target on the shares. During the last 52 weeks, Dendreon's stock has traded from a low of $2.55 to a high of $33.85. There are few signs that the momentum in this name will not continue. If their …
Thus, I'm buying here. As per Dendreon (DNDN), the stock that lost 65% of it's value yesterday based on lower earnings guidance, I think it was well overdue. It had a $6B market cap based on no current earnings and one drug, Provenge, …
Shares of the drugmaker Dendreon are plummeting in trading, a day after the company announced a restructuring that includes closing a Morris County manufacturing plant. The Seattle-based company saw its stock slide more than 22 …
The volatility of Dendreon's stock provides a fascinating insight into the allure of a new treatment modality, the bungles of the Provenge trials and the steely determination of the company to bring its first ever product to market. Dendreon's …
Shares of Dendreon (Nasdaq: DNDN) are trading significantly higher ... But how much room is left to run in the stock? …
Dendreon Corporation ( DNDN) reported fourth-quarter 2011 earnings (including stock-based compensation expense but excluding other special items) of 37 cents per share, in contrast to the Zacks Consensus Estimate loss of 31 cents …
I talked to Greg Schiffman, Dendreon’s CFO, this morning on the company’s announcement that it would raise about $46 million, after fees, by selling some of its stock to an institutional investor. Below are some highlights of that interview.
Companies whose shares are expected to trade actively in today’s session are KBR, Inc. (NYSE:KBR), Dendreon Corporation (NASDAQ:DNDN), Best Buy Co., Inc. (NYSE ... DNDN): The biotech stock has been heavily shorted for …
Many investors appear to be quite bearish on Dendreon Corporation (DNDN), especially if you look at the percentage of the float that is sold short for this stock. Currently, 26.92% of the float is sold short, suggesting an extreme level of …
Many investors appear to be quite bearish on Dendreon Corporation (DNDN), especially if you look at the percentage of the float that is sold short for this stock. Currently, 26.96% of the float is sold short, suggesting an extreme level of …